Central Garden & Pet Announces Q3 Fiscal 2022 Results

Rhea-AI Summary

Central Garden & Pet Company (NASDAQ: CENT, CENTA) reported Q3 fiscal 2022 net sales of $1,015 million, a 2% decrease year-over-year due to soft garden segment performance. Diluted GAAP EPS rose by $0.02 to $1.39, outpacing the previous year. Despite weather impacts, the garden segment's operating income increased by 13%, driven by acquisitions. However, pet segment operating income fell 12% amidst inflationary pressures. The company maintains its fiscal 2022 EPS guidance to be at or above last year, acknowledging rising costs and shifting consumer demand.

Positive

• Diluted GAAP EPS increased $0.02 to $1.39 compared to Q3 2021.
• Garden segment operating income rose 13% to $76 million, attributed to recent acquisitions.
• The company maintains fiscal 2022 GAAP EPS guidance at or above prior year.

Negative

• Net sales fell 2% to $1,015 million primarily due to weakness in the garden segment.
• Organic net sales decreased 5% compared to the previous year.
• Pet segment operating income declined 12% to $63 million amid inflationary pressures.

Q3 fiscal 2022 net sales of $1,015 million

Q3 fiscal 2022 diluted GAAP EPS of $1.39

Maintains outlook for fiscal 2022 diluted GAAP EPS at or above prior year

WALNUT CREEK, Calif.--(BUSINESS WIRE)-- Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) (“Central”), a market leader in the Garden and Pet industries, today announced financial results for its fiscal 2022 third quarter ended June 25, 2022.

“In the face of a challenging environment, Central delivered third quarter EPS two cents above the prior year quarter,” said Tim Cofer, CEO of Central Garden & Pet. “Despite softness in the garden segment due to unfavorable weather, evolving consumer behavior, reduced foot traffic and changing retailer inventory expectations, our team continued to execute well during the quarter. We remain confident in our Central to Home strategy and will make purposeful investments to capture opportunities in the pet and garden industries that will drive profitable long-term growth.”

Third Quarter Fiscal 2022 Financial Results

Net sales decreased 2% to $1,015 million compared to $1,037 million a year ago primarily due to softness in the garden segment. Organic net sales decreased 5% compared to the prior year quarter.

Gross margin of 30.3% was 60 basis points below prior year, as pricing and productivity improvements were more than offset by cost inflation in commodities, freight and labor, and unfavorable product mix.

Operating income of $114 million grew 1% compared to $113 million in the prior year. Operating margin increased 30 basis points to 11.2% despite continued inflation and heightened investment spending.

Net interest expense was $14 million compared to $13 million a year ago.

The Company's net income was $75 million, a decrease of 1% from $76 million a year ago. Diluted GAAP earnings per share for the quarter increased $0.02 to $1.39 from $1.37 in the prior year quarter. Adjusted EBITDA of $141 million was in line with $141 million a year ago.

The Company’s effective tax rate was 23.7% compared to 22.5% in the prior year quarter.

Garden Segment Third Quarter Fiscal 2022 Results

Net sales for the Garden segment decreased 4% to $511 million from $529 million a year ago as contributions from the Company's fourth quarter 2021 D&D acquisition were more than offset by a decline in organic sales of 8%. Unfavorable weather impacted the majority of the Company's garden business other than wild bird. On a two-year compound annualized growth rate basis, organic Garden segment sales increased 14% in the third quarter.

Garden segment operating income increased 13% to $76 million driven by the strong performance of recent acquisitions. Operating margin grew 210 basis points to 14.8%, mainly driven by contributions from recent acquisitions and improved pricing, partially offset by inflationary pressures and heightened investment spending. Garden segment adjusted EBITDA increased 9% to $85 million from $78 million in the prior year quarter.

Pet Segment Third Quarter Fiscal 2022 Results

Net sales for the Pet segment of $505 million were largely in line with prior year sales of $508 million, with notable contributions from the Company's dog & cat treats and toys and outdoor cushion businesses, offset by reduced sales of pet beds primarily due to SKU rationalization.

Pet segment operating income decreased 12% to $63 million, and operating margin declined 160 basis points to 12.4%. Pet segment adjusted EBITDA decreased 9% to $72 million from $80 million a year ago, largely driven by inflationary headwinds and heightened investment spending, partially offset by improved pricing.

Additional Information

The Company's cash balance at the end of the quarter was $196 million compared to $517 million a year ago.

Cash provided by operations during the quarter was $190 million compared to $299 million a year ago. The decrease in cash provided by operations was primarily due to changes in working capital driven in part by management's decision to maintain adequate inventory levels to combat a challenged supply chain as well as higher cost of inventory in this inflationary environment.

Total debt was $1.2 billion as of June 25, 2022 and June 26, 2021. The Company's leverage ratio⁽¹⁾ was 2.9x at the end of the third quarter and at the end of the prior year quarter. The Company repurchased approximately 542 thousand shares or $22.1 million of its stock during the quarter.

Fiscal 2022 Guidance

As indicated in our press release dated June 22, 2022, the Company expects fiscal 2022 GAAP EPS to be at or above prior year. The outlook takes into account increasing costs for commodities and freight, exacerbated by the current geopolitical environment, labor and a return to more normalized consumer demand patterns following extraordinary demand spanning two fiscal years. This guidance further includes anticipated pricing actions across the Company's portfolio as well as investments in capacity expansion, brand building, consumer insights, innovation and eCommerce to drive sustainable growth. This outlook does not include the impact of acquisitions that may close during fiscal 2022.

Conference Call

The Company's senior management will host a conference call today at 4:30 p.m. Eastern Time | 1:30 p.m. Pacific Time to discuss the Company's third quarter fiscal 2022 results. The conference call and related materials can be accessed at http://ir.central.com.

Alternatively, to listen to the call by telephone, dial (201) 689-8345 (domestic and international).

⁽¹⁾ Calculated using adjusted EBITDA as per the Company’s credit agreement, filed with the SEC on December 21, 2021.

About Central Garden & Pet

Central Garden & Pet (NASDAQ: CENT) (NASDAQ: CENTA) understands that home is central to life and has proudly nurtured happy and healthy homes for over 40 years. With fiscal 2021 net sales of $3.3 billion, Central is on a mission to lead the future of the Pet and Garden industries. The Company’s innovative and trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a leading portfolio of more than 65 high-quality brands including Pennington, Nylabone, Kaytee, Amdro and Aqueon, strong manufacturing and distribution capabilities and a passionate, entrepreneurial growth culture. Central Garden & Pet is based in Walnut Creek, California and has over 7,000 employees across North America and Europe. For additional information about Central, please visit www.central.com.

Safe Harbor Statement

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this release which are not historical facts, including expectations for increased levels of investment to drive capacity expansion, brand building and eCommerce, increases in labor and freight cost as well as key commodities, the accretive expectations for recent acquisitions, a return to more normalized consumer demand patterns, in addition to resuming more normal levels of travel, and their impact on future growth, and earnings guidance for fiscal 2022, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. All forward-looking statements are based upon the Company’s current expectations and various assumptions. There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in this release including, but not limited to, the following factors:

• rising inflation, a potential recession and other adverse macro-economic conditions;

• fluctuations in market prices for seeds and grains and other raw materials;

• our inability to pass through cost increases in a timely manner;

• fluctuations in energy prices, fuel and related petrochemical costs;

• declines in consumer spending and increased inventory risk during economic downturns;

• our ability to successfully manage the continuing impact of COVID-19 on our business, including but not limited to, the impact on our workforce, operations, fill rates, supply chain, demand for our products and services, and our financial results and condition;

• the potential for future reductions in demand for product categories that benefited from the COVID-19 pandemic, including the potential for reduced orders as retailers work through excess inventory;

• adverse weather conditions;

• the success of our Central to Home strategy;

• risks associated with our acquisition strategy, including our ability to successfully integrate acquisitions and the impact of purchase accounting on our financial results;

• supply chain delays and disruptions resulting in lost sales, reduced fill rates and service levels and delays in expanding capacity and automating processes;

• seasonality and fluctuations in our operating results and cash flow;

• supply shortages in pet birds, small animals and fish;

• dependence on a small number of customers for a significant portion of our business;

• consolidation trends in the retail industry;

• risks associated with new product introductions, including the risk that our new products will not produce sufficient sales to recoup our investment;

• competition in our industries;

• continuing implementation of an enterprise resource planning information technology system;

• potential environmental liabilities;

• risk associated with international sourcing;

• impacts of tariffs or a trade war;

• access to and cost of additional capital;

• potential goodwill or intangible asset impairment;

• our dependence upon our key executives;

• our ability to recruit and retain new members of our management team to support our growing businesses and to hire and retain employees;

• our inability to protect our trademarks and other proprietary rights;

• litigation and product liability claims;

• regulatory issues;

• the impact of product recalls;

• potential costs and risks associated with actual or potential cyber attacks;

• potential dilution from issuance of authorized shares;

• the voting power associated with our Class B stock; and

• the impact of new accounting regulations and the possibility our effective tax rate will increase as a result of future changes in the corporate tax rate or other tax law changes.

These risks and others are described in the Company’s Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update these forward-looking statements to reflect new information, subsequent events or otherwise. The Company has not filed its Form 10-Q for the fiscal quarter ended June 25, 2022, so all financial results are preliminary and subject to change.

CENTRAL GARDEN & PET COMPANY CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share amounts, unaudited)
ASSETS	June 25, 2022				June 26, 2021				September 25, 2021
Current assets:
Cash and cash equivalents	$	195,791			$	517,052			$	426,422
Restricted cash		12,676				11,679				13,100
Accounts receivable (less allowances of $28,106, $30,506 and $29,219)		505,896				494,432				385,384
Inventories, net		882,522				626,635				685,237
Prepaid expenses and other		36,359				32,955				33,514
Total current assets		1,633,244				1,682,753				1,543,657
Plant, property and equipment, net		390,326				306,229				328,571
Goodwill		511,973				289,955				369,391
Other intangible assets, net		490,959				125,069				134,431
Operating lease right-of-use assets		193,627				149,628				165,602
Other assets		125,797				569,870				575,028
Total	$	3,345,926			$	3,123,504			$	3,116,680
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	241,093			$	237,050			$	245,542
Accrued expenses		228,882				234,314				234,965
Current lease liabilities		45,860				39,557				40,731
Current portion of long-term debt		352				86				1,081
Total current liabilities		516,187				511,007				522,319
Long-term debt		1,185,842				1,183,591				1,184,683
Long-term lease liabilities		155,002				115,178				130,125
Deferred income taxes and other long-term obligations		136,490				71,783				56,012
Equity:
Common stock, $0.01 par value: 11,322,012, 11,336,358 and 11,335,658 shares outstanding at June 25, 2022, June 26, 2021 and September 25, 2021		113				113				113
Class A common stock, $0.01 par value: 41,745,551, 42,726,118 and 42,282,922 shares outstanding at June 25, 2022, June 26, 2021 and September 25, 2021		417				427				423
Class B stock, $0.01 par value: 1,612,374, 1,612,374 and 1,612,374 at June 25, 2022, June 26, 2021 and September 25, 2021		16				16				16
Additional paid-in capital		581,060				576,104				576,446
Retained earnings		771,341				665,534				646,082
Accumulated other comprehensive loss		(1,924	)			(1,831	)			(831	)
Total Central Garden & Pet Company shareholders’ equity		1,351,023				1,240,363				1,222,249
Noncontrolling interest		1,382				1,582				1,292
Total equity		1,352,405				1,241,945				1,223,541
Total	$	3,345,926			$	3,123,504			$	3,116,680

CENTRAL GARDEN & PET COMPANY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share amounts, unaudited)
	Three Months Ended								Nine Months Ended
	June 25, 2022				June 26, 2021				June 25, 2022				June 26, 2021
Net sales	$	1,015,378			$	1,037,075			$	2,631,146			$	2,564,557
Cost of goods sold		707,752				716,765				1,838,532				1,806,427
Gross profit		307,626				320,310				792,614				758,130
Selling, general and administrative expenses		193,547				207,069				545,476				513,239
Operating income		114,079				113,241				247,138				244,891
Interest expense		(14,422	)			(13,131	)			(43,633	)			(44,328	)
Interest income		87				45				188				322
Other (expense) income		(759	)			(1,086	)			(1,337	)			370
Income before income taxes and noncontrolling interest		98,985				99,069				202,356				201,255
Income tax expense		23,430				22,315				47,319				45,260
Income including noncontrolling interest		75,555				76,754				155,037				155,995
Net income attributable to noncontrolling interest		135				568				895				1,242
Net income attributable to Central Garden & Pet Company	$	75,420			$	76,186			$	154,142			$	154,753
Net income per share attributable to Central Garden & Pet Company:
Basic	$	1.42			$	1.41			$	2.89			$	2.87
Diluted	$	1.39			$	1.37			$	2.82			$	2.80
Weighted average shares used in the computation of net income per share:
Basic		53,237				53,976				53,392				53,882
Diluted		54,329				55,658				54,658				55,236

CENTRAL GARDEN & PET COMPANY CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands, unaudited)
	Nine Months Ended
	June 25, 2022				June 26, 2021
Cash flows from operating activities:
Net income	$	155,037			$	155,995
Adjustments to reconcile net income to net cash (used) provided by operating activities:
Depreciation and amortization		58,333				52,759
Amortization of deferred financing costs		1,982				1,577
Non-cash lease expense		36,042				29,914
Stock-based compensation		18,879				17,040
Debt extinguishment costs		169				8,577
Loss on sale of business		—				2,611
Deferred income taxes		8,199				6,992
(Gain) loss on sale of property and equipment		(53	)			62
Other		7				2,083
Change in assets and liabilities (excluding businesses acquired):
Accounts receivable		(121,392	)			(49,099	)
Inventories		(198,360	)			(85,382	)
Prepaid expenses and other assets		1,383				33,571
Accounts payable		(1,679	)			21,862
Accrued expenses		(7,072	)			10,102
Other long-term obligations		236				(640	)
Operating lease liabilities		(34,108	)			(29,402	)
Net cash (used) provided by operating activities		(82,397	)			178,622
Cash flows from investing activities:
Additions to plant, property and equipment		(98,553	)			(57,047	)
Payments to acquire companies, net of cash acquired		—				(733,614	)
Proceeds from the sale of business		—				2,400
Investments		(2,318	)			—
Other investing activities		40				(633	)
Net cash used in investing activities		(100,831	)			(788,894	)
Cash flows from financing activities:
Repayments of long-term debt		(992	)			(400,072	)
Proceeds from issuance of long-term debt		—				900,000
Borrowings under revolving line of credit		—				858,000
Repayments under revolving line of credit		—				(858,000	)
Premium paid on extinguishment of debt		—				(6,124	)
Repurchase of common stock, including shares surrendered for tax withholding		(41,834	)			(7,811	)
Payment of contingent consideration liability		(196	)			(254	)
Distribution to noncontrolling interest		(806	)			(531	)
Payment of financing costs		(2,410	)			(14,109	)
Net cash (used) provided by financing activities		(46,238	)			471,099
Effect of exchange rate changes on cash, cash equivalents and restricted cash		(1,589	)			1,507
Net decrease in cash, cash equivalents and restricted cash		(231,055	)			(137,666	)
Cash, cash equivalents and restricted cash at beginning of period		439,522				666,397
Cash, cash equivalents and restricted cash at end of period	$	208,467			$	528,731
Supplemental information:
Cash paid for interest	$	48,902			$	33,933
Cash paid for taxes	$	31,406			$	52,162
New operating lease right of use assets	$	64,504			$	63,503

Use of Non-GAAP Financial Measures

We report our financial results in accordance with accounting principles generally accepted in the United States (GAAP). However, to supplement the financial results prepared in accordance with GAAP, we use non-GAAP financial measures including non-GAAP net income and diluted net income per share, adjusted EBITDA and organic sales. Management believes these non-GAAP financial measures that exclude the impact of specific items (described below) may be useful to investors in their assessment of our ongoing operating performance and provide additional meaningful comparisons between current results and results in prior operating periods.

Adjusted EBITDA is defined by us as income before income tax, net other expense, net interest expense, depreciation and amortization and stock-based compensation (or operating income plus depreciation and amortization and stock-based compensation expense). We present adjusted EBITDA because we believe that adjusted EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. Adjusted EBITDA is used by our management to perform such evaluation. Adjusted EBITDA should not be considered in isolation or as a substitute for cash flow from operations, income from operations or other income statement measures prepared in accordance with GAAP. We believe that adjusted EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present adjusted EBITDA when reporting their results. Other companies may calculate adjusted EBITDA differently and it may not be comparable.

We have also provided organic net sales, a non-GAAP measure that excludes the impact of businesses purchased or exited in the prior 12 months, because we believe it permits investors to better understand the performance of our historical business without the impact of recent acquisitions or dispositions.

The reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. We have not provided a reconciliation of non-GAAP guidance measures to the corresponding GAAP measures on a forward-looking basis due to the potential significant variability and limited visibility of the excluded items. We believe that the non-GAAP financial measures provide useful information to investors and other users of our financial statements by allowing for greater transparency in the review of our financial and operating performance. Management also uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating our performance, and we believe these measures similarly may be useful to investors in evaluating our financial and operating performance and the trends in our business from management's point of view. While our management believes that non-GAAP measurements are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be read in conjunction with those GAAP results.

Non-GAAP financial measures reflect adjustments based on the following items:

• Incremental expenses from note redemption and issuance: we have excluded the impact of the incremental expenses incurred from the note redemption and issuance as they represent an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods. We believe the adjustment of these expenses supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance.

• Loss on sale of business: we have excluded the impact of the loss on the sale of a business as it represents an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods. We believe the adjustment of this loss supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance.

From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of providing useful information to investors and management.

The non-GAAP adjustments reflect the following:

During the first quarter of fiscal 2021, we issued $500 million aggregate principal amount of 4.125% senior notes due October 2030. We used a portion of the proceeds to redeem all of our outstanding 6.125% senior notes due 2023. As a result of our redemption of the 2023 Notes, we incurred incremental expenses of approximately $10.0 million, comprised of a call premium payment of $6.1 million, overlapping interest expense of approximately $1.4 million and a $2.5 million non-cash charge for the write-off of unamortized financing costs. These amounts are included in Interest expense in the condensed consolidated statements of operations. During the first quarter of fiscal 2021, we recognized a loss of $2.6 million, included in selling, general and administrative expense in the consolidated statement of operations, from the sale of our Breeder’s Choice business unit after concluding it was not a strategic business for our Pet segment.

			GAAP to Non-GAAP Reconciliation
			For the Three Months Ended						For the Nine Months Ended
Net Income and Diluted Net Income Per Share Reconciliation			June 25, 2022			June 26, 2021			June 25, 2022			June 26, 2021
			(in thousands, except per share amounts)
GAAP net income attributable to Central Garden & Pet Company			$	75,420		$	76,186		$	154,142		$	154,753
Incremental expenses from note redemption and issuance	(1	)		—			—			—			9,952
Loss on sale of business	(2	)		—			—			—			2,611
Tax effect of incremental redemption expenses and loss on sale				—			—			—			(2,825	)
Non-GAAP net income attributable to Central Garden & Pet Company			$	75,420		$	76,186		$	154,142		$	164,491
GAAP diluted net income per share			$	1.39		$	1.37		$	2.82		$	2.80
Non-GAAP diluted net income per share			$	1.39		$	1.37		$	2.82		$	2.98
Shares used in GAAP and non-GAAP diluted net earnings per share calculation				54,329			55,658			54,658			55,236

Organic Net Sales Reconciliation

We have provided organic net sales, a non-GAAP measure that excludes the impact of recent acquisitions and dispositions, because we believe it permits investors to better understand the performance of our historical business. We define organic net sales as net sales from our historical business derived by excluding the net sales from businesses acquired or exited in the preceding 12 months. After an acquired business has been part of our consolidated results for 12 months, the change in net sales thereafter is considered part of the increase or decrease in organic net sales.

Consolidated		GAAP to Non-GAAP Reconciliation
		For Three Months Ended June 25, 2022											For the Nine Months Ended June 25, 2022
		Net sales (GAAP)				Effect of acquisition & divestitures on increase in net sales			Net sales organic				Net sales (GAAP)				Effect of acquisition & divestitures on increase in net sales			Net sales organic
		(in millions)
Q3 FY 22		$	1,015.4			$	25.1		$	990.3			$	2,631.1			$	146.9		$	2,484.2
Q3 FY 21			1,037.1				—			1,037.1				2,564.6				3.9			2,560.7
$ increase (decrease)		$	(21.7	)					$	(46.8	)		$	66.5						$	(76.5	)
% increase (decrease)			(2.1	) %						(4.5	) %			2.6	%						(3.0	) %

Pet		GAAP to Non-GAAP Reconciliation
		For Three Months Ended June 25, 2022											For the Nine Months Ended June 25, 2022
		Net sales (GAAP)				Effect of acquisition & divestitures on increase in net sales			Net sales organic				Net sales (GAAP)				Effect of acquisition & divestitures on increase in net sales			Net sales organic
		(in millions)
Q3 FY 22		$	504.8			$	—		$	504.8			$	1,438.4			$	—		$	1,438.4
Q3 FY 21			507.8				—			507.8				1,436.2				3.9			1,432.3
$ increase		$	(3.0	)					$	(3.0	)		$	2.2						$	6.1
% increase			(0.6	) %						(0.6	) %			0.2	%						0.4	%

Garden		GAAP to Non-GAAP Reconciliation
		For Three Months Ended June 25, 2022											For the Nine Months Ended June 25, 2022
		Net sales (GAAP)				Effect of acquisition & divestitures on increase in net sales			Net sales organic				Net sales (GAAP)				Effect of acquisition & divestitures on increase in net sales			Net sales organic
		(in millions)
Q3 FY 22		$	510.6			$	25.1		$	485.5			$	1,192.7			$	146.9		$	1,045.8
Q3 FY 21			529.3				—			529.3				1,128.4				—			1,128.4
$ increase (decrease)		$	(18.7	)					$	(43.8	)		$	64.3						$	(82.6	)
% increase (decrease)			(3.5	) %						(8.3	) %			5.7	%						(7.3	) %

Adjusted EBITDA Reconciliation		GAAP to Non-GAAP Reconciliation For the Three Months Ended June 25, 2022
		Garden			Pet			Corp				Total
		(in thousands)
Net income attributable to Central Garden & Pet Company		$	—		$	—		$	—			$	75,420
Interest expense, net			—			—			—				14,335
Other expense			—			—			—				759
Income tax expense			—			—			—				23,430
Net income attributable to noncontrolling interest			—			—			—				135
Sum of items below operating income			—			—			—				38,659
Income (loss) from operations		$	75,564		$	62,616		$	(24,101	)		$	114,079
Depreciation & amortization			9,118			9,791			975				19,884
Noncash stock-based compensation			—			—			7,400				7,400
Adjusted EBITDA		$	84,682		$	72,407		$	(15,726	)		$	141,363

Adjusted EBITDA Reconciliation		GAAP to Non-GAAP Reconciliation For the Three Months Ended June 26, 2021
		Garden			Pet			Corp				Total
		(in thousands)
Net income attributable to Central Garden & Pet Company		$	—		$	—		$	—			$	76,186
Interest expense, net			—			—			—				13,086
Other expense			—			—			—				1,086
Income tax expense			—			—			—				22,315
Net income attributable to noncontrolling interest			—			—			—				568
Sum of items below operating income			—			—			—				37,055
Income (loss) from operations		$	67,037		$	71,021		$	(24,817	)		$	113,241
Depreciation & amortization			10,808			8,960			1,222				20,990
Noncash stock-based compensation			—			—			6,646				6,646
Adjusted EBITDA		$	77,845		$	79,981		$	(16,949	)		$	140,877

Adjusted EBITDA Reconciliation		GAAP to Non-GAAP Reconciliation For the Nine Months Ended June 25, 2022
		Garden			Pet			Corp				Total
		(in thousands)
Net income attributable to Central Garden & Pet Company		$	—		$	—		$	—			$	154,142
Interest expense, net			—			—			—				43,445
Other expense			—			—			—				1,337
Income tax expense			—			—			—				47,319
Net income attributable to noncontrolling interest			—			—			—				895
Sum of items below operating income			—			—			—				92,996
Income (loss) from operations		$	152,132		$	168,512		$	(73,506	)		$	247,138
Depreciation & amortization			26,457			28,879			2,997				58,333
Noncash stock-based compensation			—			—			18,879				18,879
Adjusted EBITDA		$	178,589		$	197,391		$	(51,630	)		$	324,350

Adjusted EBITDA Reconciliation		GAAP to Non-GAAP Reconciliation For the Nine Months Ended June 26, 2021
		Garden			Pet			Corp				Total
		(in thousands)
Net income attributable to Central Garden & Pet Company		$	—		$	—		$	—			$	154,753
Interest expense, net			—			—			—				44,006
Other income			—			—			—				(370	)
Income tax expense			—			—			—				45,260
Net income attributable to noncontrolling interest			—			—			—				1,242
Sum of items below operating income			—			—			—				90,138
Income (loss) from operations		$	137,650		$	176,604		$	(69,363	)		$	244,891
Depreciation & amortization			22,250			26,927			3,582				52,759
Noncash stock-based compensation			—			—			17,040				17,040
Adjusted EBITDA		$	159,900		$	203,531		$	(48,741	)		$	314,690

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20220803005741/en/

Investor Relations Contact

Friederike Edelmann

VP, Investor Relations

(925) 412-6726

fedelmann@central.com

Source: Central Garden & Pet Company

FAQ

What were Central Garden & Pet's financial results for Q3 fiscal 2022?

Central Garden & Pet reported Q3 fiscal 2022 net sales of $1,015 million, diluted GAAP EPS of $1.39, and a decrease in organic net sales by 5%.

How did the garden segment perform in Q3 fiscal 2022?

The garden segment saw net sales decrease by 4% to $511 million, though operating income grew by 13% to $76 million.

What challenges did Central Garden & Pet face in the pet segment during Q3 fiscal 2022?

The pet segment's operating income decreased by 12% to $63 million, largely due to inflationary pressures.

What is the outlook for Central Garden & Pet's fiscal 2022?

The company maintains its guidance for fiscal 2022 GAAP EPS to be at or above the prior year, despite rising costs.